>IDIX went nowhere on FDA approval Tyzeka yesterday.<
Not too surprising because almost everyone was expecting approval.
In the next few days, the share price will be affected by the clinical results at AASLD and any disclosures the company may make on tomorrow’s CC. Regards, Dew
Market Data 
Markets 
AI
